{"id":6551,"date":"2020-10-16T11:41:20","date_gmt":"2020-10-16T04:41:20","guid":{"rendered":"https:\/\/illume-emag.com\/?p=6551"},"modified":"2020-10-16T11:43:44","modified_gmt":"2020-10-16T04:43:44","slug":"japan-may-produce-the-covid-19-vaccine-by-2022","status":"publish","type":"post","link":"https:\/\/lavyon.com\/en\/japan-may-produce-the-covid-19-vaccine-by-2022\/","title":{"rendered":"Japan may produce the Covid-19 vaccine by 2022"},"content":{"rendered":"<p style=\"text-align: justify;\">Five pharmaceutical companies that are researching and developing the vaccine against SARS-CoV-2 have held a seminar in Yokohama city within the framework of the biotechnology exhibition and announced the prospect of this vaccine production.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/kenh14cdn.com\/thumb_w\/620\/2020\/10\/15\/vxin2-16027700399312122764901.jpg\" alt=\"Nh\u1eadt B\u1ea3n c\u00f3 th\u1ec3 s\u1ea3n xu\u1ea5t vaccine ng\u1eeba Covid-19 v\u00e0o n\u0103m 2022 - \u1ea2nh 1.\" title=\"\"><\/p>\n<p style=\"text-align: justify;\">A company based in Osaka says it has begun clinical trials of vaccines using new technology including DNA. According to a company speaker, even if vaccine development goes well, it will not be until the second half of 2022 that the vaccine will be available for mass production.<\/p>\n<p style=\"text-align: justify;\">A speaker from another major pharmaceutical company said the company hopes to develop a vaccine as soon as possible and aims to have a vaccine by 2022. The company is currently developing a vaccine using RNA genetic material.<\/p>\n<p style=\"text-align: justify;\">A speaker from the Pharmaceutical and Medical Device Agency, responsible for evaluating domestically produced drugs, said the agency shares a common view with the international community on efficacy and safety, and will give a fair evaluation of the vaccines, regardless of whether they are made in Japan or abroad.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Five pharmaceutical companies that are researching and developing the vaccine against SARS-CoV-2 have held a seminar in Yokohama city within the framework of the biotechnology exhibition and announced the prospect of this vaccine production. A company based in Osaka says it has begun clinical trials of vaccines using new technology including DNA. According to a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":6552,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[765],"tags":[1367,2490,2438,2440,2488,3266],"class_list":{"0":"post-6551","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-moments","8":"tag-covid-19-vaccine","9":"tag-illume-en","10":"tag-illume-e-magazine-online-cover","11":"tag-illume-emag-en","12":"tag-illume-magazine","13":"tag-japan"},"_links":{"self":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/posts\/6551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/comments?post=6551"}],"version-history":[{"count":0,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/posts\/6551\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/media\/6552"}],"wp:attachment":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/media?parent=6551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/categories?post=6551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/tags?post=6551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}